"The clinical community is expressing an interest in HepaFat-Scan and the Company is pursuing opportunities to participate in a number of studies both overseas and locally which are anticipated to start in the coming quarter" - from quarterly
These studies will lead to income soon but maybe not this quarter. That depends whether we are doing the studies with a paying client or simply participation for marketing reasons.
Finally some action, page-8
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
